- Home
- CTSH vs IQV Comparison
CTSH vs IQV Comparison
Compare CTSH & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSH
- IQV
- Stock Information
- Founded
- CTSH 1994
- IQV 1982
- Country
- CTSH United States
- IQV United States
- Employees
- CTSH N/A
- IQV N/A
- Industry
- CTSH EDP Services
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- CTSH Technology
- IQV Health Care
- Exchange
- CTSH Nasdaq
- IQV Nasdaq
- Market Cap
- CTSH 34.1B
- IQV 31.0B
- IPO Year
- CTSH 1998
- IQV 2013
- Fundamental
- Price
- CTSH $68.59
- IQV $186.02
- Analyst Decision
- CTSH Hold
- IQV Strong Buy
- Analyst Count
- CTSH 15
- IQV 20
- Target Price
- CTSH $86.36
- IQV $229.15
- AVG Volume (30 Days)
- CTSH 3.5M
- IQV 1.2M
- Earning Date
- CTSH 10-29-2025
- IQV 10-30-2025
- Dividend Yield
- CTSH 1.81%
- IQV N/A
- EPS Growth
- CTSH 12.27
- IQV N/A
- EPS
- CTSH 4.93
- IQV 6.92
- Revenue
- CTSH $20,486,000,000.00
- IQV $15,700,000,000.00
- Revenue This Year
- CTSH $8.30
- IQV $6.01
- Revenue Next Year
- CTSH $4.67
- IQV $5.05
- P/E Ratio
- CTSH $13.92
- IQV $26.81
- Revenue Growth
- CTSH 6.34
- IQV 3.60
- 52 Week Low
- CTSH $65.52
- IQV $134.65
- 52 Week High
- CTSH $90.82
- IQV $248.03
- Technical
- Relative Strength Index (RSI)
- CTSH 36.59
- IQV 50.12
- Support Level
- CTSH $68.89
- IQV $183.10
- Resistance Level
- CTSH $72.91
- IQV $191.86
- Average True Range (ATR)
- CTSH 1.38
- IQV 4.72
- MACD
- CTSH -0.16
- IQV -0.63
- Stochastic Oscillator
- CTSH 13.59
- IQV 57.30
About CTSH Cognizant Technology Solutions Corporation
Cognizant is a global IT services provider, offering consulting and outsourcing services to some of the world's largest enterprises spanning the financial services, media and communications, healthcare, natural resources, and consumer products industries. Cognizant employs nearly 350,000 people globally, roughly 70% of whom are in India, although the company's headquarters are in Teaneck, New Jersey.
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.